Sricharan Moturi, MD
Psychiatry · Franklin, TNNPI 1346459351
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $70,703 of the $82,274 with a category attached, or 85.9%. 28 manufacturers reported payments, led by AbbVie at 36.0% of the total. Reporting peaked in 2023 at $25,874 and has fallen 99.9% since, to $14 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $267.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Supernus Pharmaceuticals, Inc.$23K
- Tris Pharma Inc$17K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Neos Therapeutics, LP$1K
- Sunovion Pharmaceuticals Inc.$1K
- plus $4K from 22 others
What the payments were for
- Speaking & faculty fees$70,70386%
- Travel & lodging$4,4515%
- Food & beverage$6,9999%
- Education$1010%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $29,654 |
| Supernus Pharmaceuticals, Inc. | 39 | $22,788 |
| Tris Pharma Inc | 56 | $17,451 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $5,547 |
| Neos Therapeutics, LP | 14 | $1,420 |
| Sunovion Pharmaceuticals Inc. | 6 | $1,182 |
| Aytu Biopharma, Inc. | 2 | $1,022 |
| Jazz Pharmaceuticals Inc. | 33 | $813 |
| Ironshore Pharmaceuticals Inc. | 38 | $676 |
| Johnson & Johnson | 12 | $358 |
| Alkermes, Inc. | 7 | $303 |
| Otsuka America Pharmaceutical, Inc. | 4 | $166 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $145 |
| Indivior Inc. | 2 | $118 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| Harmony Biosciences LLC | 3 | $106 |
| Noven Therapeutics, LLC | 5 | $83 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Adlon Therapeutics L.p. | 4 | $59 |
| Lundbeck LLC | 3 | $50 |
| Corium, LLC | 2 | $30 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| Tempus AI, Inc | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Rhodes Pharmaceuticals L.p. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$28,987
- QELBREE$22,108
- Dyanavel XR$16,398
- Quillichew ER$6,407
- Quillivant$5,407
- VYVANSE$5,059
- Adzenys XR-ODT$1,178
- LATUDA$1,120
- Quillivant XR$1,000
- Cotempla XR-ODT$1,000
- ZolpiMist$1,000
- LYBALVI$436
- ARISTADA$410
- SUNOSI$243
- CAPLYTA$126
- REXULTI$122
- SUBLOCADE$117
- XYWAV$117
- SPRAVATO$106
- AUSTEDO$106
How this compares
$82,274 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 52 | $8,679 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $2,365 |
| Bupropion XlBupropion Hcl | 16 | $1,992 |
| Buprenorphine Hcl | 13 | $1,310 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $799 |
| Alprazolam | 93 | $392 |
| Escitalopram Oxalate | 20 | $231 |
| Alprazolam ErAlprazolam | 11 | $196 |
| Clonazepam | 25 | $193 |
| Zolpidem Tartrate | 19 | $107 |
| Gabapentin | 11 | $91 |
| Ondansetron Hcl | 11 | $46 |
| Trazodone Hcl | 12 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Franklin
- James HartFranklin$53K
- William BellFranklin$10K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Michelle CochranNashville$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.